TCL Archive Ratain To Lead New Center For Personalized Therapeutics At University of Chicago. Report Calls For Better Risk Stratification And New Name For DCIS. January 22, 2010
TCL Archive Phase III Regorafenib Trial Meets Endpoint Improving Progression-Free Survival April 27, 2012